Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Frontiers in Immunology|June 29, 2026
Obesity-driven metabolic reprogramming and immune dysfunction in renal cancerHenry N Ogbonna, Lyse A NorianImmunologic Research|May 20, 2014
Effects of obesity on immune responses to renal tumorsVincent Chehval, Lyse A NorianJournal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
No intrinsic deficiencies in CD8+ T cell-mediated antitumor immunity with agingLyse A Norian, Paul M AllenPlos One|September 6, 2007
Rapid maturation of effector T cells in tumors, but not lymphoid organs, during tumor regressionLyse A Norian, Paul M AllenFrontiers in Immunology|August 23, 2021
Re-Evaluating the Effects of Obesity on Cancer Immunotherapy Outcomes in Renal Cancer: What Do We Really Know?Kristine I Farag, Amani Makkouk, Lyse A NorianGynecologic Oncology Reports|July 18, 2019
Checkpoint inhibitors in ovarian cancer: A review of preclinical dataDavid W Doo, Lyse A Norian, Rebecca C ArendCancers|November 12, 2013
Advances in Viral Vector-Based TRAIL Gene Therapy for CancerLyse A Norian, Britnie R James, Thomas S GriffithFrontiers in Immunology|July 12, 2019
Targeting Glucose Metabolism to Enhance Immunotherapy: Emerging Evidence on Intermittent Fasting and Calorie Restriction MimeticsWilliam J Turbitt, Wendy Demark-Wahnefried, Courtney M Peterson, et al.Gynecologic Oncology|October 19, 2016
Metabolic risk factors and mechanisms of disease in epithelial ovarian cancer: A reviewEric R Craig, Angelina I Londoño, Lyse A Norian, et al.Geroscience|October 2, 2020
Diabetes medications as potential calorie restriction mimetics-a focus on the alpha-glucosidase inhibitor acarboseDaniel L Smith, Rachael M Orlandella, David B Allison, et al.Pageof 6